1-8 of 8 results for subject:Opren
Librarians' tools
- Search time
- 0.225 seconds
- Solr query time
- 0.001 seconds
- Search query
- subject:Opren
- We searched for
- subject_t:Opren
Type
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
What information is there as to extent to which patients suffered photosensitivity after taking Opren could be vulnerable to acute radiation skin reaction & if appropriate to advise consultants to identify such patients before recommending radiation treatment
What information is there as to extent to which patients suffered photosensitivity after taking Opren could be vulnerable to acute radiation skin reaction & if appropriate to advise consultants to identify such patients before recommending radiation treatment
What information is there as to whether any of doctors who prescribed Opren to individual patients after its product licence was withdrawn were participating in research programmes sponsored by Eli Lilly; how many people were given Opren, after its product licence was withdrawn, on a named person basis. - (Holding...
What information is there as to whether any of doctors who prescribed Opren to individual patients after its product licence was withdrawn were participating in research programmes sponsored by Eli Lilly; how many people were given Opren, after its product licence was withdrawn, on a named person basis. - (Holding...
What information has been given to medical profession regarding reasons for withdrawal of Oprens product licence & if advice was given on side effects that were thought to be associated with drug & periods of time for which they might last. - Includes ref to letter from chairman of Committee...
What information has been given to medical profession regarding reasons for withdrawal of Oprens product licence & if advice was given on side effects that were thought to be associated with drug & periods of time for which they might last. - Includes ref to letter from chairman of Committee...
To seek advice from medical advisers as to whether there are any circumstances in which they would recommend that Opren be prescribed for individual patients now that its product licence has been withdrawn.
To seek advice from medical advisers as to whether there are any circumstances in which they would recommend that Opren be prescribed for individual patients now that its product licence has been withdrawn.
Are there any plans in light of Opren case to propose amendments to law relating to medical negligence
Are there any plans in light of Opren case to propose amendments to law relating to medical negligence
Whether in light of out-of-court settlements reached in the Opren case & the fact that the court has now adjourned sine die, PQs on the subject can be answered.
Whether in light of out-of-court settlements reached in the Opren case & the fact that the court has now adjourned sine die, PQs on the subject can be answered.
Whether Committee on Safety of Medicines carried out any investigation into circumstances surrounding Eli Lilleys failure to report deaths attributed to Opren to USA Food & Drug Administration & whether Eli Lilley indicated to Committee prior to launch of Opren that drug would cause particular problems for elderly people taking...
Whether Committee on Safety of Medicines carried out any investigation into circumstances surrounding Eli Lilleys failure to report deaths attributed to Opren to USA Food & Drug Administration & whether Eli Lilley indicated to Committee prior to launch of Opren that drug would cause particular problems for elderly people taking...
What representations have been received concerning compensation in those cases where Opren has been prescribed under NHS and the patient has died.
What representations have been received concerning compensation in those cases where Opren has been prescribed under NHS and the patient has died.